|
|
Package Insert Leaflet / Information for Use
|
Summary of Product Characteristics
|
Aldurazyme® (laronidase)
100 U/ml concentrate for solution for infusion
|
PIL
|
SmPC
|
Cerezyme® (imiglucerase)
400 U Powder for concentrate for solution for infusion
|
PIL
|
SmPC
|
Cerezyme® (imiglucerase)
200 U Powder for concentrate for solution for infusion
|
PIL
|
SmPC
|
Cholestagel® (colesevelam hydrochloride)
625 mg film-coated tablets
|
PIL
|
SmPC
|
Evoltra® (clofarabine)
1mg/ml concentrate for solution for infusion
|
PIL
|
SmPC
|
Fabrazyme® (agalsidase beta)
35 mg powder for concentrate for solution for infusion
|
PIL
|
SmPC
|
Fabrazyme® (agalsidase beta)
5 mg powder for concentrate for solution for infusion
|
PIL
|
SmPC
|
Fludara® (fludarabine phosphate)
50 mg powder for solution for injection / infusion
|
PIL
|
SmPC
|
Fludara® (fludarabine phosphate)
10mg film coated tablet
|
PIL
|
SmPC
|
MabCampath® (alemtuzumab)
30mg/ml concentrate for solution for infusion
|
PIL
|
SmPC
|
MACI® (matrix-induced autologous chondrocyte implantation)
|
IFU
|
|
Modrenal® (trilostane)
Modrenal Capsules – 60 mg and 120 mg
|
PIL
|
SmPC
|
Mozobil® (plerixafor)
20 mg/ml solution for injection.
|
PIL
|
SmPC
|
Myozyme® (alglucosidase alfa)
50 mg powder for concentrate for solution for infusion
|
PIL
|
SmPC
|
Renagel® (sevelamer)
800 mg Film-coated tablets
|
PIL
|
SmPC
|
Seprafilm®
Adhesion Barrier
|
IFU
|
|
Synvisc® and Synvisc One™
(hylan G-F 20)
|
IFU
|
|
Thymoglobuline® (rabbit anti-human thymocyte immunoglobulin)
25 mg powder for solution for infusion
|
PIL
|
SmPC
|
Thyrogen® (thyrotropin alfa)
0.9 mg powder for solution for injection
|
PIL
|
SmPC
|